138 related articles for article (PubMed ID: 20726460)
1. Audit of treatment of Staphylococcus aureus bacteraemia.
Wong V; Wariyar R; Weston V; Olver WJ; Youngs E; Hussain A; Perera N; Swann A
Clin Med (Lond); 2010 Jun; 10(3):266-9. PubMed ID: 20726460
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic treatment duration and prevention of complications in neonatal Staphylococcus aureus bacteraemia.
Kempley S; Kapellou O; McWilliams A; Banerjee J; McCorqodale A; Millar M
J Hosp Infect; 2015 Oct; 91(2):129-35. PubMed ID: 26320613
[TBL] [Abstract][Full Text] [Related]
3. No effect of vancomycin MIC ≥ 1.5 mg/L on treatment outcome in methicillin-susceptible Staphylococcus aureus bacteraemia.
Bouiller K; Laborde C; Aho SL; Hocquet D; Pechinot A; Le Moing V; Bertrand X; Piroth L; Chirouze C
Int J Antimicrob Agents; 2018 May; 51(5):721-726. PubMed ID: 29305961
[TBL] [Abstract][Full Text] [Related]
4. Influence of early daptomycin therapy on treatment outcome of meticillin-resistant Staphylococcus aureus bacteraemia with high vancomycin minimum inhibitory concentrations.
Cheng CW; Hsu PC; Yang CC; Chang HJ; Siu LK; Wu TL; Huang CT; Lee MH
Int J Antimicrob Agents; 2013 Mar; 41(3):293-4. PubMed ID: 23312599
[No Abstract] [Full Text] [Related]
5. Clinical predictors of methicillin-resistance and their impact on mortality associated with Staphylococcus aureus bacteraemia.
Wi YM; Rhee JY; Kang CI; Chung DR; Song JH; Peck KR
Epidemiol Infect; 2018 Jul; 146(10):1326-1336. PubMed ID: 29781425
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.
Rehm SJ; Boucher H; Levine D; Campion M; Eisenstein BI; Vigliani GA; Corey GR; Abrutyn E
J Antimicrob Chemother; 2008 Dec; 62(6):1413-21. PubMed ID: 18782781
[TBL] [Abstract][Full Text] [Related]
7. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea.
Lee S; Song KH; Jung SI; Park WB; Lee SH; Kim YS; Kwak YG; Kim YK; Kiem SM; Kim HI; Kim ES; Park KH; Kim NJ; Jang HC; Kim HB;
Clin Microbiol Infect; 2018 Feb; 24(2):152-158. PubMed ID: 28694202
[TBL] [Abstract][Full Text] [Related]
8. Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Hall RG; Blaszczyk AT; Thompson KA; Brouse SD; Giuliano CA; Frei CR; Forcade NA; Mortensen EM; Bell T; Bedimo RJ; Alvarez CA
J Clin Pharm Ther; 2014 Dec; 39(6):653-7. PubMed ID: 25200273
[TBL] [Abstract][Full Text] [Related]
9. Knowing prior methicillin-resistant Staphylococcus aureus (MRSA) infection or colonization status increases the empirical use of glycopeptides in MRSA bacteraemia and may decrease mortality.
Robinson JO; Phillips M; Christiansen KJ; Pearson JC; Coombs GW; Murray RJ
Clin Microbiol Infect; 2014 Jun; 20(6):530-5. PubMed ID: 24224545
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
Agnello S; Wardlow LC; Reed E; Smith JM; Coe K; Day SR
Int J Antimicrob Agents; 2021 Aug; 58(2):106363. PubMed ID: 34033912
[TBL] [Abstract][Full Text] [Related]
11. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study.
Wyllie DH; Crook DW; Peto TE
BMJ; 2006 Aug; 333(7562):281. PubMed ID: 16798756
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: a case control study.
Ho KM; Robinson JO
Anaesth Intensive Care; 2009 May; 37(3):457-63. PubMed ID: 19499868
[TBL] [Abstract][Full Text] [Related]
13. Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcus aureus bacteraemia.
Chen SY; Hsueh PR; Chiang WC; Huang EP; Lin CF; Chang CH; Chen SC; Chen WJ; Chang SC; Lai MS; Chie WC
J Infect; 2014 Sep; 69(3):259-65. PubMed ID: 24797078
[TBL] [Abstract][Full Text] [Related]
14. Has the publication of methicillin-resistant Staphylococcus aureus (MRSA) treatment guidelines increased the survival associated with MRSA bacteraemia?
Brindle R;
J Antimicrob Chemother; 2009 Nov; 64(5):1111-3. PubMed ID: 19744984
[TBL] [Abstract][Full Text] [Related]
15. Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia.
Lewis PO; Heil EL; Covert KL; Cluck DB
J Clin Pharm Ther; 2018 Oct; 43(5):614-625. PubMed ID: 30003555
[TBL] [Abstract][Full Text] [Related]
16. MRSA bacteraemia.
Gould IM
Int J Antimicrob Agents; 2007 Nov; 30 Suppl 1():S66-70. PubMed ID: 17875386
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
Thwaites GE; Scarborough M; Szubert A; Saramago Goncalves P; Soares M; Bostock J; Nsutebu E; Tilley R; Cunningham R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS
Health Technol Assess; 2018 Oct; 22(59):1-148. PubMed ID: 30382016
[TBL] [Abstract][Full Text] [Related]
18. Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study.
Chang HJ; Hsu PC; Yang CC; Siu LK; Kuo AJ; Chia JH; Wu TL; Huang CT; Lee MH
J Antimicrob Chemother; 2012 Mar; 67(3):736-41. PubMed ID: 22169187
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of vancomycin serum trough concentrations and outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
Arshad S; Shoyinka A; Chen A; Jacobsen G; Zervos M
Int J Antimicrob Agents; 2012 Nov; 40(5):474-5. PubMed ID: 22883416
[No Abstract] [Full Text] [Related]
20. Predictors of clinical and microbiological treatment failure in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective cohort study in a region with low MRSA prevalence.
Forstner C; Dungl C; Tobudic S; Mitteregger D; Lagler H; Burgmann H
Clin Microbiol Infect; 2013 Jul; 19(7):E291-7. PubMed ID: 23490021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
